August 18, 2023. My curmudgeonly pal Richard Gaylord goaded me into writing this column. Richard is a chemist/physicist who sends me science-y articles and videos along with his pithy judgements, which range from “what an idiot” to “not bad.” I’ve already written about two of Richard’s most insis
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
As violence in healthcare settings rise, can bodycams in the ED enhance safety for doctors and patients?
As violence in healthcare settings rise, can bodycams in the ED enhance safety for doctors and patients?
Identification of an LGR5 as a marker for a tripotent stem/progenitor cell of the human fetal pancreas. Organoids derived from single LGR5+ cells are capable…
By capturing the genotypic and phenotypic heterogeneity of real tissues, organoids faithfully model human diseases and therapeutic responses.
Computer program finds that ChatGPT and its ilk remix words well, yet their output remains derivative
Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to sustain momentum.
Deciphering the complex interplay between neuronal activity and mitochondrial function is pivotal in understanding brain aging, a multifaceted process marked by declines in synaptic function…
Michael Kratsios and Lynne Parker would reprise their roles in first Trump administration and work with AI czar
Journalists identify papers that could violate U.N. ban on scientific ties with North Korea
